Meg specialises in U.S. corporate and securities law, advising on, among other things, general corporate matters and venture capital financing transactions, particularly in the life sciences sector.
Meg's day-to-day work focuses on advising life sciences and technology companies at all stages of development, with a particular focus on advising both companies and investors in venture capital financing transactions, from early-stage to late-stage. She also works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, and liquidity events.
Prior to joining Taylor Wessing, she spent 10 years at a top-tier firm in California, where she represented prominent U.S. and international companies and funds in life sciences and technology financing transactions and exits. She is a current member of the California Bar.
Meg particularly enjoys advising clients on complex U.S. and cross-border venture financing transactions.
Represented client utilizing a generated AI discovery platform in oversubscribed financing round with multiple strategic and institutional investors
Represented U.S. medical imaging software and device company in late-stage financing round
作者 Dannie Hanna 以及 Ross McNaughton
作者
作者
作者 Dr. Amir-Said Ghassabeh 以及 Dr. David Klein, LL.M. (Univ. of Washington), CIPP/E
作者